CYR61 (CCN1) is essential for placental development and vascular integrity

Molecular and Cellular Biology

Volumn 22, Issue 24, 2002, Pages 8709-8720

  Mo, Fan E ^a   Muntean, Andrew G ^a   Chen, Chih Chiun ^a   Stolz, Donna B ^b   Watkins, Simon C ^b   Lau, Lester F ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; CYSTEINE; CYSTEINE RICH PROTEIN 61; INTEGRIN RECEPTOR; LIGAND; SCLEROPROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN C;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHORIOALLANTOIS; EMBRYO DEATH; GENE DISRUPTION; MESODERM; MOUSE; NONHUMAN; PHENOTYPE; PLACENTA CIRCULATION; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; SYNCYTIOTROPHOBLAST;

ANIMALS; ANTIGENS, CD31; BLOOD VESSELS; CELL DIFFERENTIATION; EMBRYO; ENDOTHELIAL GROWTH FACTORS; GENE TARGETING; GENOTYPE; HUMANS; IMMEDIATE-EARLY PROTEINS; IN SITU NICK-END LABELING; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTA; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

ANIMALIA; MAMMALIA;

EID: 0036892032     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.24.8709-8720.2002     Document Type: Article

References (53)

1. Anson-Cartwright, L., K. Dawson, D. Holmyard, S. J. Fisher, R. A. Lazzarini, and J. C. Cross. 2000. The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta. Nat. Genet. 25:311-314.
2. Babic, A. M., C.-C. Chen, and L. F. Lau. 1999. Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin αVβ3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol. Cell. Biol. 19:2958-2966.
3. Babic, A. M., M. L. Kireeva, T. V. Kolesnikova, and L. F. Lau. 1998. CYR61, product of a growth factor-inducible immediate-early gene, promotes angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA 95:6355-6360.
4. Bader, B. L., H. Rayburn, D. Crowley, and R. O. Hynes. 1998. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins. Cell 95:507-519.
5. Bork, P. 1993. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett. 327:125-130.
6. Bornstein, P. 1995. Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1. J. Cell Biol. 130:503-506.
7. Brigstock, D. R. 1999. The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr. Rev. 20:189-206.
8. Cao, Y., P. Linden, J. Farnebo, R. Cao, A. Eriksson, V. Kumar, J. H. Qi, L. Claesson-Welsh, and K. Alitalo. 1998. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc. Natl. Acad. Sci. USA 95:14389-14394.
9. Chen, C.-C., N. Chen, and L. F. Lau. 2001. The angiogenic factors Cyr61 and CTGF induce adhesive signaling in primary human skin fibroblasts. J. Biol. Chem. 276:10443-10452.
10. Chen, C.-C., F.-E. Mo, and L. F. Lau. 2001. The angiogenic inducer Cyr61 induces a genetic program for wound healing in human skin fibroblasts. J. Biol. Chem. 276:47329-47337.
11. Chen, N., C. C. Chen, and L. F. Lau. 2000. Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin α6β1 and cell surface heparan sulfate proteoglycans. J. Biol. Chem. 275:24953-24961.
12. Cross, J. C., Z. Werb, and S. J. Fisher. 1994. Implantation and the placenta: Key pieces of the development puzzle. Science 266:1508-1518.
13. Dumont, D. J., G. H. Fong, M. C. Puri, G. Gradwohl, K. Alitalo, and M. L. Breitman. 1995. Vascularization of the mouse embryo: A study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev. Dyn. 203:80-92.
14. Dumont, D. J., L. Jussila, J. Taipale, A. Lymboussaki, T. Mustonen, K. Pajusola, M. Breltman, and K. Alitalo. 1998. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282:946-949.
15. Folkman, J. 2001. Angiogenesis-dependent diseases. Semin. Oncol. 28:536-542.
16. vβ3, independent of its carboxyl-terminal domain. J. Biol. Chem. 276:21943-21950.
17. Grzeszkiewicz, T. M., V. Lindner, N. Chen, S. C. T. Lam, and L. F. Lau. 2002. The angiogenic factor CYR61 supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin α6β1 and cell surface heparan sulfate proteoglycans. Endocrinology 143:1441-1450.
18. Gurtner, G. C., V. Davis, H. Li, M. J. McCoy, A. Sharpe, and M. I. Cybulsky. 1995. Targeted disruption of the murine VCAM1 gene: Essential role of VCAM-1 in chorioallantoic fusion and placentation. Genes Dev. 9:1-14.
19. Hernandez-Verdun, D. 1974. Morphogenesis of the syncytium in the mouse placenta. Ultrastructural study. Cell Tissue Res. 148:381-396.
20. Hogan, B., R. Beddington, F. Costantini, and E. Lacy. 1994. Manipulating the Mouse Embyro. Cold Spring Harbor Press, Plainview, N.Y.
21. Hurvitz, J. R., W. M. Suwairi, H. W. Van, H. El-Shanti, A. Superti-Furga, J. Roudier, D. Holderbaum, R. M. Pauli, J. K. Herd, H. E. Van, H. Rezai-Delui, E. Legius, M. M. Le, J. Al-Alami, S. A. Bahabri, and M. L. Warman. 1999. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat. Genet. 23:94-98.
22. Hynes, R. O. 1996. Targeted mutations in cell adhesion genes: What have we learned from them? Dev. Biol. 180:402-412.
23. Imai, Y., A. Moralez, U. Andag, J. B. Clarke, W. H. Busby, Jr., and D. R. Clemmons. 2000. Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions. J. Biol. Chem. 275:18188-18194.
24. Jedsadayanmata, A., C. C. Chen, M. L. Kireeva, L. F. Lau, and S. C. Lam. 1999. Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin αIIβ33. J. Biol. Chem. 274:24321-24327.
25. Kalus, W., M. Zweckstetter, C. Renner, Y. Sanchez, J. Georgescu, M. Grol, D. Demuth, R. Schumacher, C. Dony, K. Lang, and T. A. Holak. 1998. Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): Implications for IGF and IGF-I receptor interactions. EMBO J. 17:6558-6572.
26. Kireeva, M. L., S. C. T. Lam, and L. F. Lau. 1998. Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin αVβ3. J. Biol. Chem. 273:3090-3096.
27. Kireeva, M. L., B. V. Latinkic, T. V. Kolesnikova, C.-C. Chen, G. P. Yang, A. S. Abler, and L. F. Lau. 1997. Cyr61and Fisp12 are both signaling cell adhesion molecules: Comparison of activities, metabolism, and localization during development. Exp. Cell Res. 233:63-77.
28. Kireeva, M. L., F.-E. Mo, G. P. Yang, and L. F. Lau. 1996. Cyr61, product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol. Cell. Biol. 16:1326-1334.
29. Kwee, L., H. S. Baldwin, H. M. Shen, C. L. Stewart, C. Buck, C. A. Buck, and M. A. Labow. 1995. Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice. Development 121:489-503.
30. Latinkic, B. V., F.-E. Mo, J. A. Greenspan, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, and L. F. Lau. 2001. Promoter function of the angiogenic inducer Cyr61 gene in transgenic mice: Tissue specificity, inducibility during wound healing, and role of the serum response element. Endocrinology 142:2549-2557.
31. Latinkic, B. V., T. P. O'Brien, and L. F. Lau. 1991. Promoter function and structure of the growth factor-inducible immediate early gene cyr61. Nucleic Acids Res. 19:3261-3267.
32. Lau, L. F., and S. C. Lam. 1999. The CCN family of angiogenic regulators: The integrin connection. Exp. Cell Res. 248:44-57.
33. a. Leu, S.-J., S. C. T. Lam, and L. F. Lau. Proargiogenic activities of CYR61 (CCN1) mediated through integrins αvβ3 and α6β1 in human umbilical vein endothelial cells. J. Biol. Chem., in press.
34. Li, E., T. H. Bestor, and R. Jaenisch. 1992. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69:915-926.
35. Maisonpierre, P. C., C. Suri, P. F. Jones, S. Bartunkova, S. J. Wiegand, C. Radziejewski, D. Comption, J. McClain, T. H. Aldrich, N. Papadopoulos, T. J. Daly, S. Davis, T. N. Sato, and G. D. Yaneopoulos. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60.
36. O'Brien, T. P., and L. F. Lau. 1992. Expression of the growth factor-inducible immediate early gene cyr61 correlates with chondrogenesis during mouse embryonic development. Cell Growth Differ. 3:645-654.
37. O'Brien, T. P., G. P. Yang, L. Sanders, and L. F. Lau. 1990. Expression of cry61, a growth factor-inducible immediate-early gene. Mol. Cell. Biol. 10:3569-3577.
38. Perbal, B. 2001. NOV (nephroblastoma overexpressed) and the CCN family of genes: Structural and functional issues. Mol. Pathol. 54:57-79.
39. Risau, W. 1997. Mechanisms of angiogenesis. Nature 386:671-674.
40. Rossant, J., and J. C. Cross. 2001. Placental development: Lessons from mouse mutants. Nat. Rev. Genet. 2:538-548.
41. Ryseck, R.-P., H. Macdonald-Bravo, M.-G. Mattei, and R. Bravo. 1991. Structure, mapping, and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich protein. Cell Growth Differ. 2:225-233.
42. Sampath, D., R. C. Winneker, and Z. Zhang. 2001. Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: Regulation by 17beta-estradiol and overexpression in human breast cancer. Endocrinology 142:2540-2548.
43. Schober, J. M., N. Chen, T. M. Grzeszkiewicz, E. E. Emeson, T. P. Ugarova, R. D. Ye, L. F. Lau, and S. C. T. Lam. 2002. Identification of integrin αMβ2 as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): Immediate-early gene products expressed in atherosclerotic lesions. Blood 99:4457-4465.
44. Schreiber, J., E. Riethmacher-Sonnenberg, D. Riethmacher, E. E. Tuerk, J. Enderich, M. R. Bösl, and M. Wegner. 2000. Placental failure in mice lacking the mammalian homolog of glial cells missing, GCMa. Mol. Cell. Biol. 20:2466-2474.
45. Stupack, D. G., and D. A. Cheresh. 2002. ECM remodeling regulates angiogenesis: Endothelial integrins look for new ligands. Sci. Signal Transduction Knowledge Environ. 2002:PE7.
46. Su, F., M. Overholtzer, D. Besser, and A. J. Levine. 2002. WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. Genes Dev. 16:46-57.
47. Suri, C., P. F. Jones, S. Patan, S. Bartunkova, P. C. Maisonpierre, S. Davis, T. N. Sato, and G. D. Yancopoulos. 1996. Requisite role of angiopoietin-1, a ligand for the TIE-2 receptor, during embryonic angiogenesis. Cell 87:1171-1180.
48. Tsai, M. S., A. E. Hornby, J. Lakins, and R. Lupu. 2000. Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies. Cancer Res. 60:5603-5607.
49. Wong, M., M. L. Kireeva, T. V. Kolesnikova, and L. F. Lau. 1997. Cyr61, product of a growth factor-inducible immediate-early gene, regulates chondrogenesis in mouse limb bud mesenchymal cells. Dev. Biol. 192:492-508.
50. Xie, D., C. W. Miller, J. O'Kelly, K. Kakachi, A. Sakashita, J. W. Said, J. Gornbein, and H. P. Koeffier. 2001. Breast cancer: Cyr61 is over-expressed, estrogen inducible and associated with more advanced disease. J. Biol. Chem. 276:14187-14194.
51. Yancopoulos, G. D., S. Davis, N. W. Gale, J. S. Rudge, S. J. Wiegand, and J. Holash. 2000. Vascular-specific growth factors and blood vessel formation. Nature 407:242-248.
52. Yang, G. P., and L. F. Lau. 1991. Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface. Cell Growth Differ. 2:351-357.
53. Yang, J. T., H. Rayburn, and R. O. Hynes. 1995. Cell adhesion events mediated by alpha 4 integrins are essential in placental and cardiac development. Development 121:549-560.